July 24, 2026 · Form 4 insider transaction
Pande Atul bought 1,500 shares of Immunovant, Inc. at $8.43 per share, a transaction worth $12.6K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on December 26, 2025.